Analysis of Geographic Areas
Vertex Pharmaceuticals Inc. operates in 2 regions: United States and Outside of the United States.
Area Asset Turnover
Vertex Pharmaceuticals Inc., asset turnover by geographic area
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 2.79 | 4.44 | 4.17 | 3.92 | 4.00 |
| Outside of the United States | 22.56 | 41.08 | 35.79 | 29.96 | 18.03 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
| Outside of the United States | Outside of the United States area asset turnover ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Area Asset Turnover: United States
Vertex Pharmaceuticals Inc.; United States; area asset turnover calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Revenues | 6,684,900) | 6,040,400) | 5,699,300) | 5,288,300) | 4,829,282) |
| Long-lived assets | 2,392,400) | 1,359,700) | 1,365,500) | 1,348,100) | 1,207,748) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 2.79 | 4.44 | 4.17 | 3.92 | 4.00 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 6,684,900 ÷ 2,392,400 = 2.79
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Area Asset Turnover: Outside of the United States
Vertex Pharmaceuticals Inc.; Outside of the United States; area asset turnover calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Revenues | 4,335,200) | 3,828,800) | 3,231,400) | 2,286,100) | 1,376,401) |
| Long-lived assets | 192,200) | 93,200) | 90,300) | 76,300) | 76,350) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 22.56 | 41.08 | 35.79 | 29.96 | 18.03 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 4,335,200 ÷ 192,200 = 22.56
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Outside of the United States | Outside of the United States area asset turnover ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Revenues
Vertex Pharmaceuticals Inc., revenues by geographic area
US$ in thousands
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 6,684,900) | 6,040,400) | 5,699,300) | 5,288,300) | 4,829,282) |
| Outside of the United States | 4,335,200) | 3,828,800) | 3,231,400) | 2,286,100) | 1,376,401) |
| Total | 11,020,100) | 9,869,200) | 8,930,700) | 7,574,400) | 6,205,683) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Long-lived assets
Vertex Pharmaceuticals Inc., long-lived assets by geographic area
US$ in thousands
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 2,392,400) | 1,359,700) | 1,365,500) | 1,348,100) | 1,207,748) |
| Outside of the United States | 192,200) | 93,200) | 90,300) | 76,300) | 76,350) |
| Total | 2,584,600) | 1,452,900) | 1,455,800) | 1,424,400) | 1,284,098) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).